母亲百日咳免疫接种:临床获益与流行病学遗留影响
在许多常规疫苗接种覆盖率高的国家,百日咳发病率上升令人担忧,美国报告病例每年接近50,000例,为1950年代以来未见水平。母亲免疫接种被提出作为保护新生儿(重症百日咳和死亡风险较高)的有效策略,但母源抗体可能通过钝化效应不利影响常规免疫程序的免疫原性,可能导致群体免疫逐渐退化。本文讨论母亲免疫接种可能的长期流行病学效应。
要点
- 美国百日咳报告病例每年接近50,000例,为1950年代以来未见水平。
- 母亲免疫接种被提出作为保护新生儿的有效策略。
- 母源抗体可能通过钝化效应影响常规免疫程序免疫原性,可能导致群体免疫退化。
核心结论
- 母亲免疫接种被提出作为保护新生儿的有效策略,但若母源抗体通过钝化效应不利影响常规免疫程序免疫原性,可能观察到群体免疫逐渐退化。
研究设计与样本
- 本文为观点文章(Perspective),讨论母亲免疫接种可能的长期流行病学效应。
主要发现
- 许多常规疫苗接种覆盖率高的国家百日咳发病率上升,美国报告病例每年接近50,000例,为1950年代以来未见水平。
- 新生儿在出生至首次常规疫苗接种剂量之间的时间窗口内重症百日咳和死亡风险较高。
- 若母源抗体通过钝化效应不利影响常规免疫程序免疫原性,可能观察到群体免疫逐渐退化。
- 「浪费的」疫苗将导致易感儿童在人群中积累,特别导致老年年龄组发病率总体增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The increase in whooping cough (pertussis) incidence in many countries with high routine vaccination coverage is alarming, with incidence in the US reaching almost 50,000 reported cases per year, reflecting incidence levels not seen since the 1950s. While the potential explanations for this resurgence remain debated, we face an urgent need to protect newborns, especially during the time window between birth and the first routine vaccination dose. Maternal immunisation has been proposed as an effective strategy for protecting neonates, who are at higher risk of severe pertussis disease and mortality. However, if maternally derived antibodies adversely affect the immunogenicity of the routine schedule, through blunting effects, we may observe a gradual degradation of herd immunity. 'Wasted' vaccines would result in an accumulation of susceptible children in the population, specifically leading to an overall increase in incidence in older age groups. In this Perspective, we discuss potential long-term epidemiological effects of maternal immunisation, as determined by possible immune interference outcomes.
引用
- Bento AI, King AA, Rohani P, et al. Maternal pertussis immunisation: clinical gains and epidemiological legacy. Euro Surveill. 2017. PMID: 28449735. doi:10.2807/1560-7917.ES.2017.22.15.30510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。